Navigation Links
Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/13/2008

passcode 72272011. A replay of this call will be available until February 27, 2008 by phone at 1-888-286-8010 (U.S.), or 1-617-801-6888 (international), using the passcode 23908777.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. For further information see http://www.JazzPharmaceuticals.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements, including, but not limited to, statements related to the anticipated regulatory approval and planned commercial launch of LUVOX CR and the continued development of Jazz Pharmaceuticals' product candidates. These forward-looking statements are based on the company's current expectations and inherently involve significant risks and uncertainties. Jazz Pharmaceuticals' actual results and the timing of events could differ materially from those anticipated in such forward looking statements as a result of these risks and uncertainties, which include, without limitation, the risk that the FDA may not approve LUVOX CR for marketing in the United States; risks related to the launch of LUVOX CR; risks related to the development of Jazz Pharmaceuticals' product candidates, including the risk that study or clinical trial results may require Jazz Pharmaceuticals to discontinue the development of one or more product candidates; and risks related to the uncertain and time-consuming regulatory approval process. These and other risk factors are discussed under "Risk Factors" in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2007 filed by Jazz Pharmaceuticals with the Securities and Exchange Commission on November 9, 2007. Jazz Pharmaceuticals undertakes no duty or obligati
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
2. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
3. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
4. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
5. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
6. NPS Pharmaceuticals, Inc. Announces an Increase in Tender Offer Price for Its 3.0% Convertible Notes Due 2008 and Extends Expiration Date Until October 17, 2007
7. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
8. Jazz Pharmaceuticals, Inc. Announces Changes to its Board of Directors
9. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
10. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
11. Jazz Pharmaceuticals, Inc. to Announce Third Quarter 2007 Financial Results on November 6, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Nov.25/PRNewswire-Asia/--SinovacBiotechLtd.(SVA),...daythatitexecuted,ajointventure(JV)agreementtoesta...ovacDalian).TheJVwillresearch,develop,produce,andc...eitsexpertise,andexperienceindevelopingandcommerci...itslanduserights,manufacturingfacilitiesand,establ...
(Date:11/24/2009)... Ambassador to also Visit Detroit , ... , ,Who: David Appia, French Ambassador for Intern...vest in France Agency, , , , ,What: Ambassador Ap...ent pro-business initiatives adopted by France to ... landscape for innovation and development., , ,Whe...
(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--Sigma-AldrichCorpor...conferenceonTuesday,December1stat1:45PMGMTinLondon...iobroadcastovertheInternetavailableat http://inve...the"Webcast"icontoaccessthisfile. ,, AboutSig...HighTechnologycompany.Itschemicalandbiochemicalpro...
(Date:11/24/2009)...,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxyannounced...asapprovedthe,investigationalnewdrugapplication(IN...sulinformulationtotreatdiabetes.ThisIND,approvalal..., Diabetesisadisordercharacteristicofhighbloo...tesoftenresultinseveremicro-and,macro-vasculardise...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Biolaxy Secures IND Approval for Oral Insulin 2
...,(Nasdaq: HOLX ) today announced that Glenn Muir,... Sun Trust Robinson Humphrey,s 37th Annual,Confere... Hotel in,Buckhead, GA., Interested parties are i...c,s investor presentation on Wednesday, April 16, ...ction of the Company,s website at, http://www.holo...
...nounced today a,major new release of its IDEAS(R) ... 3.0 incorporates greatly expanded analytical capa...use., IDEAS 3.0 provides the user with dozens of ...ng features to strengthen morphological,data analy...much greater,flexibility in defining specific area...
...rnational, Inc. (OTC Bulletin Board: CCEL) (the "C...blished family cord blood banks, today,announced r...08., Consolidated revenues for the first quarter ...ely flat, as compared to approximately $4.2,millio...ted a net loss in,the first quarter 2008 of approx...
Other Biology Technology:Hologic to Present at the Sun Trust Robinson Humphrey's 37th Annual Institutional Conference 2Amnis Announces Release of Powerful New Image Data Analysis Software 2Cryo-Cell International, Inc. Reports First Quarter 2008 Results 2Cryo-Cell International, Inc. Reports First Quarter 2008 Results 3Cryo-Cell International, Inc. Reports First Quarter 2008 Results 4Cryo-Cell International, Inc. Reports First Quarter 2008 Results 5
(Date:11/24/2009)...EW YORK (November 24, 2009) -- The Wildlife Conser...aling that the last remaining population of Siberi... the rising tide of poaching and habitat loss. , ...Russian officials of what needs to be done to prot...at. , The report was released by th...
(Date:11/23/2009)...earch presents strong evidence that the "synergist...traffic-related pollution and indoor endotoxin cau...other exposure alone. , Environmental health s...lege of Medicine have shown that children exposed ...nd indoor endotoxin during early life are six time...
(Date:11/23/2009)... More than 160 participants gathered this week for...S INITIATIVE conference. This year,s topic, "Synth...ers, and medical researchers to explore the engine...he emerging field of synthetic biology. , Bonnie...nceton University and this year,s conference chair...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Statement From the National Pork Board on Testing of Pigs for H1N1 59692 1Omnicell to Release Third Quarter 2009 Earnings Results on October 22 59690 1Omnicell to Release Third Quarter 2009 Earnings Results on October 22 59690 2Virginia Restaurants Urged to Go Completely Smoke Free After Major Report Finds Smoke Free Laws Prevent Heart Attacks 59687 1Virginia Restaurants Urged to Go Completely Smoke Free After Major Report Finds Smoke Free Laws Prevent Heart Attacks 59687 2Virginia Restaurants Urged to Go Completely Smoke Free After Major Report Finds Smoke Free Laws Prevent Heart Attacks 59687 3
...sity Of Southern California School Of Dentistry ha...ft palate and the process that leads to palate for... congenital birth defects, occurring in one out of...children of American Indian, Hispanic or Asian des...eft lip, females are twice as likely to have a cle...
... a study on fetal alcohol syndrome, researchers we...to cells in a key area of the fetal brain by block...ng the acidic environment that alcohol produces. T...sponsible for balance and muscle coordination, is ...ing development. , The researchers also found tha...
...ability, WALL, N.J., July 28 BIO-key Internation...reless public safety and,finger-based biometric id...hieved profitability and strong revenue growth for...evenue from continuing operations for the quarter ...f 40.9% from the $2.5 million reported,for the qua...
Other Biology News:USC researchers identify alternate pathway that leads to palate development 2USC researchers identify alternate pathway that leads to palate development 3Researchers block damage to fetal brain following maternal alcohol consumption 2BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008 2BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008 3BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008 4BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008 5
...l infusion kits reduce the time and expense of pre...le equipment to reduce the risk of infection. Each...including swivel, tubing, tether and connectors. T... you specify, preassembled in Instech's clean room...
7890A GC from Agilent Technologies
...all for critical, but time-consuming optimization ...es siRNA transfection protocols resulting in less ...n can be used to efficiently transfect adherent ce...otoxicity. From start to finish, successful gene s...
...Pan-Caspase In Situ Assay Kit is a fluorescent-bas... undergoing apoptosis. The kit is for research use...ocedures. CHEMICON®s CaspaTag™ Pan-Caspa...ct active caspases. The methodology is based on Fl...
Biology Products: